UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
☒
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR
THE QUARTERLY PERIOD ENDED DECEMBER 31, 2023
Commission
File Number 000-56112
GENUFOOD
ENERGY ENZYMES CORP.
(Exact
name of registrant as specified in its charter)
Nevada
(State
or other jurisdiction of incorporation or organization)
1108
S. Baldwin Avenue, Suite 107
Arcadia,
California 91007
(Address
of principal executive offices, including zip code.)
(855)
707-2077
(Telephone
number, including area code)
Securities
registered pursuant to Section 12(b) of the Act: None
Title of Each Class | | Trading Symbol(s) | | Name of Each Exchange on Which Registered |
N/A | | N/A | | N/A |
Check
whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the last 90 days. YES ☒ NO ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). YES ☒ NO ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller
reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
Emerging growth company | ☐ | | |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☒
State
the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 808,900,041
shares as of February 15, 2024
GENUFOOD
ENERGY ENZYMES CORP.
FORM
10-Q FOR THE THREE-MONTH PERIOD ENDED DECEMBER 31, 2023
TABLE
OF CONTENTS
ITEM
1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
GENUFOOD ENERGY ENZYMES CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
| |
December 31, | | |
September 30, | |
| |
2023 | | |
2023 | |
| |
(Unaudited) | | |
| |
Assets | |
| | |
| |
Current assets | |
| | |
| |
Cash and cash equivalents | |
$ | 19,617 | | |
$ | 125,924 | |
Prepayment | |
| 8,000 | | |
| 8,187 | |
Total Current Assets | |
| 27,617 | | |
| 134,111 | |
| |
| | | |
| | |
Equipment | |
| 96,142 | | |
| 67,451 | |
| |
| | | |
| | |
Total Assets | |
$ | 123,759 | | |
$ | 201,562 | |
| |
| | | |
| | |
Liabilities and Stockholders’ (Deficit) Equity | |
| | | |
| | |
Current liabilities | |
| | | |
| | |
Accounts payable | |
$ | 111,849 | | |
$ | 100,849 | |
Accrued expenses | |
| 37 | | |
| 37 | |
Due to related parties | |
| 4,437 | | |
| 14,730 | |
Total Current Liabilities | |
| 116,323 | | |
| 115,616 | |
| |
| | | |
| | |
Commitment and contingencies (Note 8) | |
| 32,976 | | |
| 32,226 | |
| |
| | | |
| | |
Stockholders’ (Deficit) Equity | |
| | | |
| | |
Common stock: $0.001 par value; 10,000,000,000 shares authorized; 808,900,041 shares issued and outstanding as of December 31, 2023 and September 30, 2023 | |
| 808,900 | | |
| 808,900 | |
Additional paid-in capital | |
| 17,008,342 | | |
| 16,989,592 | |
Discount on common stock | |
| (7,241,581 | ) | |
| (7,241,581 | ) |
Accumulated deficit | |
| (10,601,201 | ) | |
| (10,503,191 | ) |
Total Stockholders’ (Deficit) Equity | |
| (25,540 | ) | |
| 53,720 | |
| |
| | | |
| | |
Total Liabilities and Stockholders’ (Deficit) Equity | |
$ | 123,759 | | |
$ | 201,562 | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
GENUFOOD ENERGY ENZYMES CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
| |
For the Three Months Ended
December 31, | |
| |
2023 | | |
2022 | |
| |
| | |
(Restated) | |
Revenue | |
$ | - | | |
$ | - | |
| |
| | | |
| | |
Operating expenses | |
| | | |
| | |
General and administrative expenses | |
| 95,616 | | |
| 148,995 | |
Total operating expenses | |
| 95,616 | | |
| 148,995 | |
| |
| | | |
| | |
Loss from operations | |
| (95,616 | ) | |
| (148,995 | ) |
| |
| | | |
| | |
Other income (expense) | |
| | | |
| | |
Interest expense | |
| (44 | ) | |
| - | |
Foreign currency loss | |
| - | | |
| (43 | ) |
Other non-operating income (expenses), net | |
| (750 | ) | |
| (750 | ) |
Total other (expense) income | |
| (794 | ) | |
| (793 | ) |
| |
| | | |
| | |
Loss before income taxes | |
| (96,410 | ) | |
| (149,788 | ) |
| |
| | | |
| | |
Provision for income taxes | |
| 1,600 | | |
| - | |
| |
| | | |
| | |
Net loss | |
| (98,010 | ) | |
| (149,788 | ) |
| |
| | | |
| | |
Other comprehensive income (loss) | |
| | | |
| | |
Foreign currency transaction adjustment | |
| - | | |
| (85 | ) |
| |
| | | |
| | |
Comprehensive loss | |
$ | (98,010 | ) | |
$ | (149,873 | ) |
| |
| | | |
| | |
Loss per share of common stock - basic and diluted | |
| * | | |
| * | |
| |
| | | |
| | |
Weighted average shares outstanding - basic and diluted | |
| 808,900,041 | | |
| 299,686,921 | |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
GENUFOOD ENERGY ENZYMES CORPORATION
CONDENSED CONSOILDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
(UNAUDITED)
| |
| | |
| | |
| | |
| | |
Accumulated | | |
| |
| |
Common
Stock | | |
Additional | | |
Discount on | | |
| | |
Other | | |
Total | |
| |
Number
of | | |
| | |
Paid-in- | | |
common | | |
Accumulated | | |
Comprehensive | | |
Stockholder’s | |
| |
Shares | | |
Amount | | |
Capital | | |
stock | | |
Deficit | | |
Income
(loss) | | |
Equity | |
Balance
at September 30, 2023 | |
| 808,900,041
| | |
$ | 808,900 | | |
$ | 16,989,592 | | |
$ | (7,241,581 | ) | |
$ | (10,503,191 | ) | |
$ | - | | |
$ | 53,720 | |
Stock-based
compensation | |
| - | | |
| - | | |
| 18,750 | | |
| - | | |
| - | | |
| - | | |
| 18,750 | |
Net
Loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (98,010 | ) | |
| - | | |
| (98,010 | ) |
Balance
at December 31, 2023 | |
| 808,900,041 | | |
$ | 808,900 | | |
$ | 17,008,342 | | |
$ | (7,241,581 | ) | |
$ | (10,601,201 | ) | |
$ | - | | |
$ | (25,540 | ) |
| |
| | |
| | |
| | |
| | |
| | |
Accumulated | | |
| |
| |
Common
Stock | | |
Additional | | |
Discount on | | |
| | |
Other | | |
Total | |
| |
Number
of | | |
| | |
Paid-in- | | |
common | | |
Accumulated | | |
Comprehensive | | |
Stockholder’s | |
| |
Shares | | |
Amount | | |
Capital | | |
stock | | |
Deficit | | |
Income
(loss) | | |
Equity | |
Balance
at September 30, 2022 (restated) | |
| 299,686,921 | | |
$ | 299,687 | | |
$ | 16,927,592 | | |
$ | (7,241,581 | ) | |
$ | (9,875,489 | ) | |
$ | (193,558 | ) | |
$ | (83,349 | ) |
Stock-based
compensation (restated) | |
| - | | |
| - | | |
| 18,750 | | |
| - | | |
| - | | |
| - | | |
| 18,750 | |
Foreign
currency translation | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (85 | ) | |
| (85 | ) |
Net
loss (restated) | |
| - | | |
| - | | |
| - | | |
| - | | |
| (149,788 | ) | |
| - | | |
| (149,788 | ) |
Balance
at December 31, 2022 (restated) | |
| 299,686,921 | | |
$ | 299,687 | | |
$ | 16,946,342 | | |
$ | (7,241,581 | ) | |
$ | (10,025,277 | ) | |
$ | (193,643 | ) | |
$ | (214,472 | ) |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
GENUFOOD ENERGY ENZYMES CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| |
For the Three Months Ended | |
| |
December 31, | |
| |
2023 | | |
2022 | |
| |
| | |
(Restated) | |
Cash Flows from Operating Activities | |
| | | |
| | |
Net loss | |
$ | (98,010 | ) | |
$ | (149,788 | ) |
Adjustments to reconcile net loss to net cash used in operating activities | |
| | | |
| | |
Stock-based compensation | |
| 18,750 | | |
| 18,750 | |
Change in operating assets and liabilities | |
| | | |
| | |
Prepayment | |
| 187 | | |
| 7,836 | |
Accounts payable | |
| 11,000 | | |
| 17,401 | |
Due to related parties | |
| (10,293 | ) | |
| 30,182 | |
Commitment and contingencies | |
| 750 | | |
| 750 | |
Net cash used in operating activities | |
| (77,616 | ) | |
| (74,869 | ) |
| |
| | | |
| | |
Cash Flows from Investing Activities | |
| | | |
| | |
Purchase of equipment | |
| (28,691 | ) | |
| (15,005 | ) |
Net cash used in investing activities | |
| (28,691 | ) | |
| (15,005 | ) |
| |
| | | |
| | |
Net decrease in cash and cash equivalents | |
| (106,307 | ) | |
| (89,874 | ) |
| |
| | | |
| | |
Cash and cash equivalents, beginning of period | |
| 125,924 | | |
| 136,400 | |
| |
| | | |
| | |
Cash and cash equivalents, end of period | |
$ | 19,617 | | |
$ | 46,526 | |
| |
| | | |
| | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |
| | | |
| | |
Cash paid for interest | |
$ | - | | |
$ | - | |
Cash paid for income taxes | |
$ | 1,600 | | |
$ | - | |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
GENUFOOD
ENERGY ENZYMES CORP
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE
1 – GENERAL ORGANIZATION AND BUSINESS
Genufood
Energy Enzymes Corp., USA (the “Company” or “GEEC”) was incorporated under the laws of the State of Nevada on
June 21, 2010. On February 13, 2012, GEEC incorporated a wholly-owned subsidiary, Genufood Enzymes (S) Pte Ltd (“GESPL”)
in Singapore, which was dissolved on January 9, 2023.
Since
its inception, the Company has always been in the development stage and never generated significant revenues. The Company is currently
developing business in Electric Vehicle Charge station. The Company has engaged in business agreements and development with various parties.
The Company has initiated its electric vehicle charging station business.
On
August 1, 2022, the board of directors (the “Board”) of the Company unanimously approved to expand our business in the area
of electric vehicle supply equipment (“EVSE”) and will direct the management team to implement its new business plan in such
industry. On August 16, 2022, the Company formally announced its intention to reposition as EVSE solutions provider, seeking to grow
business in EVSE industry, including building, owning, and operating the next generation of electric vehicle charging stations in the
U.S. The Company intends to bring convenient, reliable, and accessible charging experience to electric vehicle drivers, utilizing frictionless
technology and carbon-neutral vehicle-charging infrastructure.
On
October 26, 2022, the Company entered into three Charging Station Site Host Agreements (the “Agreements”) with two institutions
(the “Site Hosts”), respectively, pursuant to which the Site Hosts agree to allow the Company to install its electric vehicle
charging stations at the locations set forth in the Agreements (the “Charging Stations”). Under the Agreements, the Company
has agreed to share the revenue generated by the sales of electricity at the Charging Stations with the Site Hosts.
As
of December 31, 2023, the Company has two sites under construction for charging stations and three sites under planning.
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
Company’s condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States of America (“US GAAP”). The accompanying condensed consolidated financial statements reflect all adjustments,
consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of
operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending September
30, 2024. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements
and related notes included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2023.
Principle
of Consolidation
The
condensed consolidated financial statements include the accounts of GEEC and its wholly-owned subsidiary GESPL. All significant inter-company
accounts and transactions have been eliminated in consolidation. The wholly-owned subsidiary of the Company did not have business activities
prior to its dissolution.
Use
of Estimates
The
preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates.
Concentrations
of Credit Risk
Financial
instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash, to the extent
balances exceeded limits that were insured by the Federal Deposit Insurance Corporation. The Company does not require collateral and
maintains reserves for potential credit losses. Such losses have historically been immaterial and have been within management’s
expectations.
Cash
and Cash Equivalents
The
Company considers all highly liquid instruments with original maturities of three months or less when acquired to be cash equivalents.
As of December 31, 2023 and September 30, 2023, the Company did not have cash equivalents.
Fair
Value of Financial Instruments
The
Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”),
with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy
that prioritizes the inputs used in measuring fair value as follows:
|
● |
Level
1 inputs are quoted prices available for identical assets and liabilities in active markets. |
|
|
|
|
● |
Level
2 inputs are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and
liabilities in active markets or other inputs that are observable or can be corroborated by observable market data. |
|
|
|
|
● |
Level
3 inputs are less observable and reflect our own assumptions. |
The
Company’s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued expenses and due
to related parties. The carrying amounts of such financial instruments in the accompanying consolidated balance sheets approximate their
fair values due to their relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant
currency or credit risks arising from these financial instruments.
Foreign
Currency Translation and Transactions
The
reporting and functional currency of GEEC is the USD. The functional currency of GESPL, a wholly owned subsidiary of GEEC, is the Singapore
Dollar (“SGD”).
For
financial reporting purposes, the financial statements of the Company’s Singapore subsidiary, which are prepared using the SGD,
are translated into the Company’s reporting currency, USD. Assets and liabilities are translated using the exchange rate on the
balance sheet date, which was 0.6970 as of September 30, 2022. Revenue and expenses are translated using average exchange rates prevailing
during each reporting period. The 0.7214 average exchange rates were used to translate revenues and expenses for the three months ended
December 31, 2022. Stockholders’ equity is translated at historical exchange rates. Adjustments resulting from the translation
are recorded as a separate component of accumulated other comprehensive loss in stockholders’ deficit.
Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transactions. The resulting exchange difference, presented as foreign currency transaction loss, is included in the
accompanying consolidated statements of operations.
Business
Segments
The
Company operates in only one segment.
Net
Income (Loss) Per Share
The
Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic loss per share is computed
by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share
is computed similar to basic income (loss) per share except that the denominator is increased to include the number of additional common
shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares
were dilutive. There were no potential dilutive debt or equity instruments issued and outstanding at any time during the three months
ended December 31, 2023 and 2022.
Discounts
on Common Stock
Common
stock issued lower than the Company’s par value is treated as common stock issued under discounts. The portion of the discount
is shown separately as a deduction from the Company’s account of common stock on the Company’s consolidated financial statements.
Stock-Based
Compensation
The
Company accounts for its stock-based compensation in which the Company obtains employee services in share-based payment transactions
under FASB ASC Topic 718, Compensation – Stock Compensation, which requires the Company to expense the cost of employee services
received in exchange for an award of equity instruments based on the grant date fair value of such instruments over the vesting period.
Income
Taxes
Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect
on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
A valuation allowance is recorded to reduce the Company’s deferred tax assets to the amount that is more likely than not to be
realized.
The
Company considers positive and negative evidence when determining whether a portion or all of its deferred tax assets will more likely
than not be realized. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses,
forecasts of future profitability, the duration of statutory carry-forward periods, its experience with tax attributes expiring unused,
and its tax planning strategies. The ultimate realization of deferred tax assets is dependent upon its ability to generate sufficient
future taxable income within the carry-forward periods provided for in the tax law and during the periods in which the temporary differences
become deductible. When assessing the realization of deferred tax assets, the Company has considered possible sources of taxable income
including (i) future reversals of existing taxable temporary differences, (ii) future taxable income exclusive of reversing temporary
differences and carry-forwards, (iii) future taxable income arising from implementing tax planning strategies, and (iv) specific known
trend of profits expected to be reflected within the industry.
The
Company recognizes a tax benefit associated with an uncertain tax position when, in its judgment, it is more likely than not that the
position will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition
threshold, the Company initially and subsequently measures the tax benefit as the largest amount that the Company judges to have a greater
than 50% likelihood of being realized upon ultimate settlement with a taxing authority. The Company’s liability associated with
unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the progress of tax audits, case law developments
and new or emerging legislation. Such adjustments are recognized entirely in the period in which they are identified. The Company’s
effective tax rate includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered
appropriate by management. The Company classifies interest and penalties recognized on the liability for unrecognized tax benefits as
income tax expense.
There
were no current and deferred income tax provision recorded for the three months ended December 31, 2023 and 2022 since the Company has
recurring losses.
Recent
Accounting Pronouncements
The
Company considers the applicability and impact of all Accounting Standards Updates (“ASUs” or “ASU”) on the Company’s
consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected
to have minimal impact on the Company’s consolidated financial position or results of operations. Recently issued ASUs that the
Company feels may be applicable to the Company are as follows:
In
August 2020, the FASB issued Accounting Standards Update No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20)
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). The subtitle is Accounting for Convertible
Instruments and Contracts in an Entity’s Own Equity. This ASU addresses complex financial instruments that have characteristics
of both debt and equity. The application of this ASU would reduce the number of accounting models for convertible debt instruments and
convertible preferred stock. Limiting the accounting models would result in fewer embedded conversion features being separately recognized
from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1)
those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a
derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with
substantial premiums for which the premiums are recorded as paid-in capital. To date, no such bifurcation has been necessary. Management
is evaluating the potential impact. This ASU becomes effective for fiscal years beginning after December 15, 2023.
NOTE
3 – GOING CONCERN
As
of December 31, 2023 and September 30, 2023, the Company had an accumulated deficit of $10,601,201 and $10,503,191, respectively. To
date, the Company’s cash flow requirements have been primarily met through proceeds received from sales of its common stock. These
and other factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial
statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and
liabilities that may result in the Company not being able to continue as a going concern.
The
Company received $362,000 from private placement during the year ended September 30, 2023. The proceeds have been used for operation
expenses. Management is currently seeking additional funds for future operation.
NOTE
4 – EQUIPMENT
As
of December 31, 2023 and September 30, 2023 the Company had equipment of $96,142 and $67,451, respectively, consisting of equipment to
be installed at its electric vehicle charging stations and related installation costs.
NOTE
5 – STOCKHOLDERS’ EQUITY (DEFICIT)
The
Company is authorized under its articles of incorporation, as amended, to issue 10,000,000,000 shares of Common Stock, par value $0.001
per share.
On
February 24, 2023, the Company conducted a private placement offering and sold 375,000,000 shares of common stock at $0.001 per share,
for gross proceeds of $375,000, and incurred offering costs of $13,000.
On
March 24, 2023, the Company issued 134,213,120 shares of common stock to its board of directors, officers, and former officers to repay
the compensation due to them in the aggregate amount of $134,213 at the conversion rate of $0.001 per share.
Stock
Options
On
July 15, 2022, the CEO, David Tang, was granted 15,000,000 options to purchase shares at $0.01 per share. As of December 31, 2023, total
options granted was 15,000,000 and 5,312,500 was vested. This option will be subject to a vesting schedule providing for twenty-five
percent (25%) vesting after the first twelve (12) months of employment and monthly vesting as to the remaining seventy-five percent (75%)
of the shares over the following thirty-six (36) months after the first anniversary of the employment commencement date. These stock
options are exercisable over a maximum period of 10 years from the grant date. The weighted average grant date fair value of options
granted during the year ended September 30, 2022 was $0.02.
Compensation
costs associated with the Company’s stock options are recognized, based on the grant-date fair value of these options, over the
requisite service period, or vesting period. Accordingly, the Company recognized stock-based compensation expense of $18,750 and $18,750,
respectively, which was included in the general and administrative expenses in the consolidated statements of operations for the three
months ended December 31, 2023 and 2022.
The
fair value of the stock options listed above was determined using the Black-Scholes option pricing model with the following assumptions:
| |
December 31, 2023 | |
Risk-free interest rate | |
| 2.99 | % |
Expected term | |
| 6.08 years | |
Expected volatility | |
| 379.35 | % |
Expected dividend yield | |
| 0 | % |
The
following is a summary of the option activity for the three months ended December 31, 2023:
Options | |
Number of Underlying Shares | | |
Weighted average exercise price | | |
Weighted Average Remaining Contractual Life (years) | | |
Aggregate Intrinsic Value | |
Outstanding at October 1, 2023 | |
| 15,000,000 | | |
$ | 0.01 | | |
| – | | |
$ | – | |
Granted | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
Exercised | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
Forfeited or expired | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
Outstanding at December 31, 2023 | |
| 15,000,000 | | |
$ | 0.01 | | |
| 8.5 | | |
$ | – | |
Vested and expected to vest as of December 31, 2023 | |
| 15,000,000 | | |
$ | 0.01 | | |
| 8.5 | | |
$ | – | |
Exercisable at December 31, 2023 | |
| 5,312,500 | | |
$ | 0.01 | | |
| 8.5 | | |
$ | – | |
As
of December 31, 2023, unrecognized total compensation cost associated with these options was $190,428. This expense is expected
to be recognized over a weighted-average period of 2.54 years.
NOTE
6 – RELATED PARTY TRANSACTIONS
Related
Parties
Name
of related parties |
|
Relationship
with the Company |
Yi Lung
(Oliver) Lin |
|
Principal shareholder |
Jui Pin
(John) Lin |
|
Principal shareholder, Chairman of the Board, President, and Director |
Jia Tian
(Jeffery) Lin |
|
Former Chief Executive Officer |
Wen-Piao
(Jack) Lai |
|
Director |
Shao-Cheng
(Will) Wang |
|
Former Chief Financial Officer |
Kuang
Ming (James) Tsai |
|
Director and Chief Financial Officer |
Hsin-Ta
(Darren) Su |
|
Director, Treasurer |
Hui-Chuan
(Sandra) Lin |
|
Director and Secretary, daughter of Jui Pin (John) Lin |
David
Tang |
|
Chief Executive Officer |
Due
to Related Parties
The
Company’s due to related parties balances are as follows:
| |
December 31, 2023 | | |
September 30, 2023 | |
Hsin-Ta (Darren) Su | |
$ | 1,496 | | |
$ | 707 | |
David Tang | |
| 2,941 | | |
| 14,023 | |
Total | |
$ | 4,437 | | |
$ | 14,730 | |
The
related party balances are unsecured, interest-free and due on demand.
NOTE
7 – INCOME TAXES
The
Company has not generated any revenue from any source in the United States and had consolidated net loss for all the years since inception
in 2010. Management believes GEEC does not have any U.S. income tax liability due. However, even though the Company does not have U.S.
income tax liability, it may be required to file Form 5471 each year with the Internal Revenue Service (the “IRS”) of Department
of Treasury. GEEC falls in the Category Five Filer (as a domestic corporation). The Company used to have subsidiaries: GEECIS in Sri
Lanka that was established in May 2011, GESPL in Singapore that was established in February 2012, and GESTL in Thailand that was established
in December 2014. The subsidiaries in Sri Lanka and Thailand were disposed in 2014 and 2016, respectively. The Singapore subsidiary has
been inactive since 2016 and dissolved in January 2023.
Internal
Revenue Code (“IRC”) Section 6038(a) requires information reporting with respect to certain foreign corporations (Form 5471)
and describes the information required to be reported on this form. IRC Section 6038(b)(1) provides for a monetary penalty of $10,000
for each Form 5471 that is filed after the due date of the income tax return (including extensions) or does not include the complete
and accurate information described in Section 6038(a). According to IRS rules, a penalty may apply to each Form 5471 which is filed after
the due date of the income tax return. The penalty will be applied whether or not any tax is due on Form 1120.
The
Company believes that based on the current information available, it is difficult to determine whether it is probable that the Company
will be charged penalties by IRS for the late filing of Form 5471 and even if it will be, it is difficult to reasonably estimate the
amount of penalties that may be assessed.
During
the fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information
Return of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September
30, 2020. The Company has engaged an outside professional advisor to seek for forgiveness of the penalty and interest thereon in the
amount of $7,976, for a total of $32,976, which was still pending as of December 31, 2023.
NOTE
8 – COMMITMENTS AND CONTINGENCIES
The
Company terminated its previous virtual office agreement in Los Angeles, California and has established a new virtual office in Arcadia,
California. The new arrangement is on a month-to-month basis at a cost of $200 per month. As of December 31, 2023, the Company has no
material commitments under operating leases.
During
the fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information
Return of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September
30, 2020 (see Note 7).
NOTE
9 – SUBSEQUENT EVENTS
Management
has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date when the
consolidated financial statements were issued and determined that no subsequent events occurred that would require adjustment to or disclosure
in the consolidated financial statements.
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This
document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995,
Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements
of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not
limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of
management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic
conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing.
Forward-looking
statements may include the words “may,” “could,” “will,” “estimate,” “intend,”
“continue,” “believe,” “expect”, “anticipate”, “hope” or other similar words.
These forward-looking statements present our estimates and assumptions only as of the date of this report. Except for our ongoing obligation
to disclose material information as required by the federal securities laws, we do not intend, and undertake no obligation, to update
any forward-looking statement.
Although
we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially
from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as
well as any forward-looking statements, are subject to change and inherent risks and uncertainties. Some of the key factors impacting
these risks and uncertainties include, but are not limited to:
| ● | risks
related to our ability to identify, pursue and commence a reverse merger and/or a possible operating business; |
| ● | our
ability to obtain adequate funding to complete a reverse merger or commence a possible operating business and meet our operating expenses
on a current basis; |
| ● | general
economic uncertainty, whether as a result of the COVID-19 pandemic or otherwise; |
| ● | delays
in our ability to obtain any necessary business licenses and permits, and commence business operations, whether as a result of the COVID-19
pandemic or otherwise; and |
| ● | current
and longer-term economic and other impacts of the COVID-19 pandemic on our operations, results of operations and financial condition,
including without limitation changes in consumer spending patterns for non-essential products, resulting from the economic crisis caused
by lockdown, shelter-in-place, stay-at-home or similar orders instituted as a result of the pandemic, or otherwise. |
Overview
On
August 1, 2022, the board of directors (the “Board”) of the Company unanimously approved to expand our business in the area
of electric vehicle supply equipment (“EVSE”) and will direct the management team to implement its new business plan in such
industry. On August 16, 2022, the Company formally announced its intention to reposition as EVSE solutions provider, seeking to grow
business in EVSE industry, including building, owning, and operating the next generation of electric vehicle charging stations in the
U.S. The Company intends to bring convenient, reliable, and accessible charging experience to electric vehicle drivers, utilizing frictionless
technology and carbon-neutral vehicle-charging infrastructure.
On
October 26, 2022, we entered into three Charging Station Site Host Agreements (the “Agreements”) with two institutions (the
“Site Hosts”), respectively, pursuant to which the Site Hosts agree to allow us to install our electric vehicle charging
stations at the locations set forth in the Agreements (the “Charging Stations”). Under the Agreements, we have agreed to
share our revenue generated by the sales of electricity at the Charging Stations with the Site Hosts in accordance with the schedules
set forth therein.
As
of December 31, 2022, the Company has purchased certain electric vehicle charging equipment. Furthermore, the Company is in the process
of obtaining permits to construct the Charging Stations at the three confirmed sites. As of December 31, 2022, the Company contracted
an architectural firm on providing design and engineering services for the two sites and working on technical issues for the third site.
As
of February 13, 2023, the Company has received the finalized site plans and electrical diagrams from the architectural firm and electrical
engineers for 2 sites. The Company has also received permission from the site owners to proceed with the charging station construction
permit applications with the local municipalities. The Company expects to install up to a total of 10 charging units for the first two
sites and expects to have them operational in early 2024.
Results
of Operations
Three
Months Ended December 31, 2023 compared to the Three Months Ended December 31, 2022
Revenues
We
did not generate any revenues during the three months ended December 31, 2023 and 2022.
Operating
Expenses
We
incurred total operating expenses of $95,616 and $148,995 for the three months ended December 31, 2023 and 2022, respectively. Our operating
expenses consist of business development expenses, legal fees, other professional fees, payroll expenses, stock-based compensation, rent,
bank charges, and transfer agent fees. The decrease in operating expenses for the three months ended December 31, 2023 compared to the
same period ended in 2022 was primarily due to decrease in payroll expenses.
Other
expense
During
the three months ended December 31, 2023, we incurred $794 other expenses mainly due to interest incurred for unpaid penalty from IRS.
During the three months ended December 31, 2022, we incurred $793 other expenses mainly due to interest incurred for unpaid penalty from
IRS.
Net
Loss
As
a result of the above, our net loss decreased from $149,788 in the three months ended December 31, 2022 to $98,010 in the same period
ended in 2023.
Liquidity
and Capital Resources
Working
Capital
| |
December 31, | | |
September 30, | |
| |
2023 | | |
2023 | |
Current Assets | |
$ | 27,617 | | |
$ | 134,111 | |
Current Liabilities | |
| 116,323 | | |
| 115,616 | |
Working Capital (Deficit) | |
$ | (88,706 | ) | |
$ | 18,495 | |
As
of December 31, 2023, we had current assets of $27,617 and a working capital deficit of $88,706. In comparison, as of September 30, 2023,
we had current assets of $134,111 and a working capital surplus of $18,495.
We
had $116,323 in total current liabilities as of December 31, 2023, consisting of $111,849 in accounts payable, $37 in accrued expenses,
and $4,437 due to related parties. This is compared to total current liabilities of $115,616 in total current liabilities as of September
30, 2023, consisting of $100,849 in accounts payable, $37 in accrued expenses, and $14,730 in due to related parties. The decrease in
due to related parties was primarily due to unpaid compensation to officers and directors repaid.
We
had total stockholders’ deficit of $25,540 and an accumulated deficit of $10,601,201 as of December 31, 2023. In comparison, we
had a total stockholders’ equity of $53,720 and an accumulated deficit of $10,503,191 as of September 30, 2023.
Cash
Flows
| |
Three months
ended December 31, 2023 | | |
Three months
ended December 31, 2022 | |
Cash flows used in operating activities | |
$ | (77,616 | ) | |
$ | (74,869 | ) |
Cash flows used in investing activities | |
| (28,691 | ) | |
| (15,005 | ) |
Cash flows provided by financing activities | |
| - | | |
| - | |
Effect of exchange rate changes on cash | |
| - | | |
| - | |
Net decrease in cash during period | |
$ | (106,307 | ) | |
$ | (89,874 | ) |
During
the three months ended December 31, 2023, we used $77,616 of cash in operating activities which was attributable primarily to our net
loss of $98,010 offset by stock-based compensation, and change in operating assets and liabilities of $20,394. In comparison, during
the three months ended December 31, 2022, we used $74,869 of cash in operating activities which was attributable primarily to our net
loss of $149,788 offset by stock-based compensation and change in operating assets and liabilities of $74,919.
During
the three months ended December 31, 2023, we used $28,691 of cash investing activity in purchase of equipment. During the three months
ended December 31, 2022, we used $15,005 of cash investing activity in purchase of equipment.
During
the three months ended December 31, 2023 and 2022, we did not have any financing activity.
There
is substantial doubt that we can continue as an ongoing business for the next twelve months unless we obtain additional capital to pay
our expenses as they become due. We do not anticipate any significant additional revenue until and unless we begin to execute our plan
of operations involving the start of our new electric vehicle charging station business. There is no assurance that we will ever reach
that stage. The condensed consolidated financial statements presented herein do not include any adjustments relating to the recoverability
and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event that we
cannot continue as a going concern.
Our
ability to continue as a going concern is dependent upon our ability to successfully execute our business plan and generate profitable
operations in the future, and, until and unless we achieve that, to obtain the necessary financing to meet our obligations and repay
our liabilities arising from normal business operation as and when they become due. To date, our capital requirements have primarily
been funded by shareholders through the purchase of our Common Stock in private offerings and short-term borrowings from a former officer
and another shareholder.
Contractual
Obligations
We
do not have material contractual obligations and commitments. We only have one lease that is renewed on a month-to-month basis.
Off-Balance
Sheet Arrangements
As
of December 31, 2023, we had not entered into any other financial guarantees or other commitments to guarantee the payment obligations
of any third parties. As of December 31, 2023, we had not entered into any derivative contracts that are indexed to our shares and classified
as shareholder’s equity or that are not reflected in our condensed consolidated financial statements. Furthermore, as of December
31, 2023, we had not had any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit,
liquidity or market risk support to such entity. As of December 31, 2023, we had not had any variable interest in any unconsolidated
entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development
services with us.
Critical
accounting policies and estimates
Our
discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements,
which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed
consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities,
revenues and expenses, and related disclosure of contingent assets and liabilities. We continually evaluate our estimates, including
those related to income taxes, and the valuation of equity transactions. We base our estimates on historical experience and on various
other assumptions that we believed to be reasonable under the circumstances, the results of which form the basis for making judgments
about the carrying values of assets and liabilities that are not readily apparent from other sources. Any future changes to these estimates
and assumptions could cause a material change to our reported amounts of revenues, expenses, assets and liabilities. Actual results may
differ from these estimates under different assumptions or conditions. For the three months ended December 31, 2023, and 2022, no significant
estimates and assumptions have been made in the condensed consolidated financial statements. The following are some of the critical accounting
policies in relation to the preparation of the condensed consolidated financial statements. For a full summary of our critical accounting
policies, please refer to Note 2 to the Consolidated Financial Statements.
Stock-Based
Compensation
We
account for stock-based compensation in which we obtain employee services in share-based payment transactions under FASB ASC Topic 718,
Compensation – Stock Compensation, which requires us to expense the cost of employee services received in exchange for an award
of equity instruments based on the grant date fair value of such instruments over the vesting period.
Recent
accounting pronouncements
We
do not expect that the adoption of recently issued accounting pronouncements will have a material impact on our financial position, results
of operations, or cash flows. For a full summary of recent accounting pronouncements, please refer to Note 2 to the Consolidated Financial
Statements.
ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.
Not
required for smaller reporting companies.
ITEM
4. CONTROLS AND PROCEDURES.
Evaluation
of Disclosure Controls and Procedures
Our
disclosure controls and procedures are designed to ensure that the information relating to our Company, including our consolidated subsidiary,
required to be disclosed in our reports filed with the Securities and Exchange Commission (the “SEC”) is recorded, processed,
summarized and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management,
including our chief executive officer and chief financial officer, as appropriate to allow for timely decisions regarding required disclosure.
We conducted an evaluation, under the supervision and with the participation of management, including our chief executive officer and
chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this annual report.
Based on this evaluation, our chief executive officer and chief financial officer concluded that, as of the evaluation date, our disclosure
controls and procedures were not effective due to material weaknesses in our internal control over financial reporting, as described
below.
Management’s
Report on Internal Control Over Financial Reporting
Our
management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined
in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of management, including our chief executive
officer and chief financial officer, we conducted an evaluation of the design and operating effectiveness of our internal controls over
financial reporting based on the framework in “Internal Control-Integrated Framework (2013)” issued by the Committee of Sponsoring
Organizations of the Treadway Commission (“COSO”).
Our
internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that,
in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets; (ii) provide reasonable assurance
that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of management and directors;
and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our
assets that could have a material effect on the consolidated financial statements.
Management
assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2023 and identified the
following material weaknesses:
Inadequate
Segregation of Duties: We have an inadequate number of personnel to properly implement control procedures.
Comingling
of funds: We do not have adequate control of our petty cash, resulting in the comingling of our petty cash with the nominal account
holder’s personal funds.
Lack
of Adequate Staffing: We do not have adequate in-house accounting personnel and expertise in key positions, which resulted in overly
relying on outside consultants in preparing financial statements and other required disclosures by the Securities and Exchange Commission.
Ineffective
oversight: We do not exercise effective oversight and monitoring procedures designed and implemented to certain control activities.
Overly
relied on outside professionals: We are unable to prepare internally financial statements and relied on outside professional consultants
to prepare financial statements and adequate disclosures.
A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is
a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented
or detected on a timely basis. As a result of the material weaknesses in internal control over financial reporting identified above,
management concluded that the Company’s internal control over financial reporting was not effective as of December 31, 2023, based
on the criteria set forth in “Internal Control-Integrated Framework” issued by COSO.
Due
to the nature of the material weaknesses, there is a more than remote likelihood that misstatements which could be material to the annual
or interim financial statements could occur that would not be prevented or detected. The material weaknesses identified above either
individually or in aggregation did not result in any identified misstatements or errors in the Company’s condensed consolidated
financial statements at and for the three-month period ended December 31, 2023.
Management’s
Plan for Remediation
Management
has discussed the material weaknesses noted above with our independent registered public accounting firm. Management is committed to
improving its internal controls and, subject to having adequate financial resources, intends to:
| ● | increase
the frequency of independent reconciliations of significant accounts which will mitigate the lack of segregation of duties to monitor
and review until there are sufficient personnel to segregate duties; |
| ● | consider
providing professional courses for our key position personnel; |
| ● | hire
additional employees to realize segregation of duties; and |
| ● | strengthen
management monitoring control over accounting and financial statements preparation processing. |
However,
due to limitation of funds and personnel, we have so far been unable to begin to implement the plan to remediate the material weaknesses
noted above and it is uncertain when we will be able to begin to implement the plan to remediate these material weaknesses.
Inherent
Limitations on Effectiveness of Controls
A
control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s
objectives will be met. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all
control issues or misstatements. Accordingly, our controls and procedures are designed to provide reasonable, not absolute, assurance
that the objectives of our control system are met. Projections of any evaluation of effectiveness to future periods are subject to the
risk that controls may become adequate because of changes in conditions, or that the degree of compliance with the policies or procedures
may deteriorate.
Changes
in Internal Control
There
have been no changes in our internal control over financial reporting that occurred during the period covered by this report that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART
II
OTHER
INFORMATION
ITEM
1. LEGAL PROCEEDINGS
We
are not currently a party to any lawsuit or proceeding, which, in the opinion of management, is likely to have a material adverse effect
on us or our business.
ITEM
1A. RISK FACTORS
Not
required of smaller reporting companies.
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM
4. MINE SAFETY DISCLOSURES
Not
applicable.
ITEM
5. OTHER INFORMATION
None.
ITEM
6. EXHIBITS
* | The
certifications attached as Exhibits 32.1 and 32.2 accompany this quarterly report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Registrant for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended. |
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
|
GENUFOOD ENERGY
ENZYMES CORP. |
|
|
|
Date: February 20, 2024 |
By: |
/s/
David Tang |
|
|
David
Tang |
|
|
Chief
Executive Officer |
|
|
|
By: |
/s/
Kuang Ming (James) Tsai |
|
|
Kuang Ming (James) Tsai |
|
|
Director, Chief Financial
Officer |
19
NONE
Yes
Yes
299686921
808900041
false
--09-30
Q1
2024
false
0001510518
00-0000000
true
0001510518
2023-10-01
2023-12-31
0001510518
2024-02-15
0001510518
2023-12-31
0001510518
2023-09-30
0001510518
us-gaap:RelatedPartyMember
2023-12-31
0001510518
us-gaap:RelatedPartyMember
2023-09-30
0001510518
2022-10-01
2022-12-31
0001510518
us-gaap:CommonStockMember
2023-09-30
0001510518
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0001510518
gfoo:DiscountOnCommonStockMember
2023-09-30
0001510518
us-gaap:RetainedEarningsMember
2023-09-30
0001510518
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-09-30
0001510518
us-gaap:CommonStockMember
2023-10-01
2023-12-31
0001510518
us-gaap:AdditionalPaidInCapitalMember
2023-10-01
2023-12-31
0001510518
gfoo:DiscountOnCommonStockMember
2023-10-01
2023-12-31
0001510518
us-gaap:RetainedEarningsMember
2023-10-01
2023-12-31
0001510518
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-10-01
2023-12-31
0001510518
us-gaap:CommonStockMember
2023-12-31
0001510518
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001510518
gfoo:DiscountOnCommonStockMember
2023-12-31
0001510518
us-gaap:RetainedEarningsMember
2023-12-31
0001510518
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0001510518
gfoo:RestatedMember
us-gaap:CommonStockMember
2022-09-30
0001510518
gfoo:RestatedMember
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0001510518
gfoo:RestatedMember
gfoo:DiscountOnCommonStockMember
2022-09-30
0001510518
gfoo:RestatedMember
us-gaap:RetainedEarningsMember
2022-09-30
0001510518
gfoo:RestatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-09-30
0001510518
gfoo:RestatedMember
2022-09-30
0001510518
gfoo:RestatedMember
us-gaap:CommonStockMember
2022-10-01
2022-12-31
0001510518
gfoo:RestatedMember
us-gaap:AdditionalPaidInCapitalMember
2022-10-01
2022-12-31
0001510518
gfoo:RestatedMember
gfoo:DiscountOnCommonStockMember
2022-10-01
2022-12-31
0001510518
gfoo:RestatedMember
us-gaap:RetainedEarningsMember
2022-10-01
2022-12-31
0001510518
gfoo:RestatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-10-01
2022-12-31
0001510518
gfoo:RestatedMember
2022-10-01
2022-12-31
0001510518
gfoo:RestatedMember
us-gaap:CommonStockMember
2022-12-31
0001510518
gfoo:RestatedMember
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001510518
gfoo:RestatedMember
gfoo:DiscountOnCommonStockMember
2022-12-31
0001510518
gfoo:RestatedMember
us-gaap:RetainedEarningsMember
2022-12-31
0001510518
gfoo:RestatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-12-31
0001510518
gfoo:RestatedMember
2022-12-31
0001510518
2022-09-30
0001510518
2022-12-31
0001510518
2022-10-01
2023-09-30
0001510518
2023-02-24
0001510518
2023-02-24
2023-02-24
0001510518
2023-03-24
0001510518
2023-03-24
2023-03-24
0001510518
srt:ChiefExecutiveOfficerMember
2022-07-15
2022-07-15
0001510518
srt:ChiefExecutiveOfficerMember
2022-07-15
0001510518
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2023-12-31
0001510518
us-gaap:StockOptionMember
gfoo:VestingMember
2023-10-01
2023-12-31
0001510518
gfoo:VestingMember
2023-10-01
2023-12-31
0001510518
us-gaap:StockOptionMember
2023-10-01
2023-12-31
0001510518
us-gaap:StockOptionMember
2021-10-01
2022-09-30
0001510518
gfoo:YiLungOliverLinMember
2023-10-01
2023-12-31
0001510518
gfoo:JuiPinJohnLinMember
2023-10-01
2023-12-31
0001510518
gfoo:JiaTianJefferyLinMember
2023-10-01
2023-12-31
0001510518
gfoo:WenPiaoJackLaiMember
2023-10-01
2023-12-31
0001510518
gfoo:ShaoChengWillWangMember
2023-10-01
2023-12-31
0001510518
gfoo:KuangMingJamesTsaiMember
2023-10-01
2023-12-31
0001510518
gfoo:HsinTaDarrenSuMember
2023-10-01
2023-12-31
0001510518
gfoo:HuiChuanSandraLinMember
2023-10-01
2023-12-31
0001510518
gfoo:DavidTangMember
2023-10-01
2023-12-31
0001510518
us-gaap:RelatedPartyMember
gfoo:HsinTaDarrenSuMember
2023-12-31
0001510518
us-gaap:RelatedPartyMember
gfoo:HsinTaDarrenSuMember
2023-09-30
0001510518
us-gaap:RelatedPartyMember
gfoo:DavidTangMember
2023-12-31
0001510518
us-gaap:RelatedPartyMember
gfoo:DavidTangMember
2023-09-30
0001510518
us-gaap:RelatedPartyMember
2023-12-31
0001510518
us-gaap:RelatedPartyMember
2023-09-30
0001510518
2021-09-30
0001510518
2019-10-01
2020-09-30
0001510518
2020-10-01
2021-09-30
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the quarterly report of Genufood
Energy Enzymes Corp. (the “Company”) on Form 10-Q for the quarter ended December 31, 2023, as filed with the Securities and
Exchange Commission (the “Report”), I, David Tang, Chief Executive Officer (Principal Executive Officer) of the Company, hereby
certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of
my knowledge:
In connection with the quarterly report of Genufood
Energy Enzymes Corp. (the “Company”) on Form 10-Q for the quarter ended December 31, 2023, as filed with the Securities and
Exchange Commission (the “Report”), I, Kuang Ming (James) Tsai, Director, Chief Financial Officer (Principal Financial Officer)
of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code,
that to the best of my knowledge: